Estimation of mutation rate at human glycophorin A locus in hematopoietic stem cell progenitors

Environmental and Molecular Mutagenesis

Volumn 39, Issue 4, 2002, Pages 333-341

  Vickers, M A ^a   Hoy, T ^b   Lake, H ^b   Kyoizumi, S ^c   Boyse, J ^a   Hewitt, M ^d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Childhood; Glycophorin A; Mutation; Mutation rate; Stem cells

Indexed keywords

GLYCOPHORIN A; HLA A ANTIGEN; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ADOLESCENT; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; CHILD; CHILD DEVELOPMENT; CONFERENCE PAPER; CONTROLLED STUDY; ERYTHROCYTE; GENE LOCUS; HEMATOPOIETIC STEM CELL; HETEROZYGOTE; HUMAN; HUMAN CELL; MUTATION RATE; NEWBORN; PREDICTION; SIMULATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ERYTHROPOIESIS; FEMALE; GLYCOPHORIN; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION;

EID: 0036307901     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10076     Document Type: Conference Paper

References (48)

1. Evidence that hematopoiesis may be a stochastic process in vivo
2. Mutation frequency in human blood cells increases with age
3. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human blood
4. In vivo somatic mutations in humans: Measurement and analysis
5. In vivo mutations in human blood cells: Biomarkers for molecular epidemiology
6. Probability
7. Stem cells: The intestinal stem cell as a paradigm
8. Progressive telomere shortening in aplastic anemia
9. Functional isolation and characterisation of human hematopoietic stem cells
10. Mutator phenotypes in human colorectal carcinoma cell lines
11. Human in vivo somatic mutation measured at two loci: Individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies
12. "Stochastic" - 40 Years of use and abuse
13. Estimation of mutation rates based on the analysis of polypeptide constituents of cultured human lymphoblastoid cells
14. Reference ranges and normal values: Blood volume
15. Quantitative measurement of the erythrocytic and granulocytic cells of the marrow and blood
16. Molecular characterization of glycophorin A transcripts in human erythroid cells using RT-PCR, allele-specific restriction and sequencing
17. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer
18. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke
19. Mutator phenotype of Werner syndrome is characterized by extensive deletions
20. In vivo somatic mutation and segregation at the human glycophorin A (GPA) locus: Phenotypic variation encompassing both gene-specific and chromosomal mechanisms
21. Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes
22. Creation of human tumour cells with defined genetic elements
23. Telomere reduction in human colorectal carcinoma and with ageing
24. Mutations in human lymphocytes studied by an HLA selection system
25. Direct immunofluorescence labelling provides an improved method for the glycophorin A somatic cell mutation assay
26. Frequency of variant erythrocytes at the glycophorin A locus in two Bloom's syndrome patients
27. Measurements of the frequency of human erythrocytes with gene expression loss pheno-types at the glycophorin A locus
28. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors
29. An improved flow cytometric assay for somatic mutations at the glycophorin A locus in humans
30. Mutations of bacteria from virus sensitivity to virus resistance
31. Sensitivity of somatic mutations in human umbilical cord blood to maternal environments
32. Somatic mutations are frequent and increase with age in human kidney epithelial cells
33. The HLA-A assay: Improved technique and normal results
34. Molecular analysis of spontaneous hypoxanthine phosphoribosyltransferase mutations in thioguanine-resistant HL-60 human leukaemia cells
35. Measurement of in vivo mutations in human lymphocytes
36. A statistical model to estimate variance in long-term low-dose mutation assays: Testing of the model in a human lymphoblastoid mutation assay
37. The effect of T-lymphocyte "clonality" on the calculated hprt mutation frequency occurring in vivo in humans
38. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood and blood stem cells
39. Loss of heterozygosity and base substitution at the APRT locus in mismatch-repair-proficient and -deficient colorectal carcinoma cell lines
40. Neonatal vitamin K administration and in vivo somatic mutation
41. Intercorrelations and sources of variability in three mutagenicity assays: A population-based study
42. Mutation rate of normal and malignant human lymphocytes
43. Cellularity and cell proliferation rates in human bone marrow. II. Studies on generation times and radiothymidine uptake of human red cell precursors
44. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways
45. Modelling haemopoietic stem cell division by analysis of mutant red cells
46. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay
47. A clonal marker induced by mutation in mouse intestinal epithelium